financetom
Business
financetom
/
Business
/
Update: Advisory Egan-Jones Endorses 7 Ancora Nominees to NSC Board
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Advisory Egan-Jones Endorses 7 Ancora Nominees to NSC Board
May 3, 2024 6:40 AM

09:07 AM EDT, 05/03/2024 (MT Newswires) -- (Updates headline and article with original report from advisory firm)

Advisory firm Egan-Jones backed a slate of seven nominees endorsed by activist shareholder Ancora Holdings to the board of Norfolk Southern ( NSC ) railroad.

"We believe that voting FOR ALL the Ancora Nominees is in the best interest of the Company and its shareholders," Egan-Jones said in the report, which was shared with MT Newswires.

The consultancy cited management's leadership ability, its handling of the 2023 East Palestine, Ohio, disaster, and four other derailments this year among reasons for recommending the overhaul.

Egan-Jones said its director nominee slate "will provide a pathway for growth and competent railroad services and restore public trust at the same time."

Previously, Institutional Shareholder Services endorsed five of Ancora's seven nominees to the 13-member board, while Glass Lewis recommended that shareholders elect six of its seven candidates at the May 9 annual meeting

Norfolk Southern ( NSC ) did not immediately reply to MT Newswires' requests for comment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CAMP4 Analyst Highlights Rare Disease Platform Potential
CAMP4 Analyst Highlights Rare Disease Platform Potential
Nov 9, 2024
In October, CAMP4 Therapeutics Corporation ( CAMP ) priced its initial public offering of 6.82 million at $11.00 per share, with approximately $75 million in gross proceeds. Camp4 is an RNA therapeutics company focused on developing therapies for rare diseases. CAMP4 Therapeutics ( CAMP ) dosed the first participant in its Phase 1 study of CMP-CPS-001 for urea cycle disorders...
--Huntsman Keeps Quarterly Dividend at $0.25 a Share, Payable Dec. 31 to Stockholders of Record Dec. 13
--Huntsman Keeps Quarterly Dividend at $0.25 a Share, Payable Dec. 31 to Stockholders of Record Dec. 13
Nov 9, 2024
04:52 PM EST, 11/05/2024 (MT Newswires) -- Price: 20.46, Change: -0.29, Percent Change: -1.40 ...
Mercury Systems Swings to Fiscal Q1 Adjusted Earnings; Revenue Rises -- Shares Up After Hours
Mercury Systems Swings to Fiscal Q1 Adjusted Earnings; Revenue Rises -- Shares Up After Hours
Nov 9, 2024
04:52 PM EST, 11/05/2024 (MT Newswires) -- Mercury Systems ( MRCY ) reported fiscal Q1 adjusted earnings late Tuesday of $0.04 per share, swinging from an adjusted loss of $0.24 a year earlier. Analysts polled by Capital IQ expected a loss of $0.08. Revenue for the quarter ended Sept. 27 was $204.4 million, up from $181 million a year earlier....
Harvard University must face narrowed lawsuit over antisemitism
Harvard University must face narrowed lawsuit over antisemitism
Nov 9, 2024
Nov 5 (Reuters) - A U.S. judge overseeing lawsuits accusing Harvard University of antisemitism on Tuesday narrowed but refused to dismiss a case by two advocacy groups accusing the Ivy League school of making it unbearable for Jewish students to study there. U.S. District Judge Richard Stearns said the Louis D. Brandeis Center for Human Rights Under Law and Jewish...
Copyright 2023-2026 - www.financetom.com All Rights Reserved